Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $475

Benzinga Newsdesk www.benzinga.com Negative 82.2%

Neg 82.2% Neu 0% Pos 0%

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $510 to $475.